Company Overview:
Through its partners and assuming pending transactions under review by the TSXV are approved, LGC presently will have interests in over 450,000 square feet of planted cannabis in Jamaica, Switzerland, Italy, and Australia. That is expected to increase to over 2,100,000 square feet by 2021, as its portfolio companies execute their expansion plans, in addition to the anticipated licensing of Tricho-Med’s operations in Quebec, Canada.
LGC partners currently sell cannabis products in over 1,000 points of sale across Switzerland and Italy under the ONE Premium Cannabis and EasyJoint brands as well as medical cannabis oils in Australia under the Little Green Pharma brand. LGC’s partners’ branded products are available in a variety of formats including dry cannabis flower, tinctures, oils, seeds, and beverages.
[stock_market_chart symbol=”LG.V” range=”1y” settings='{“primaryChartType”:”smoothedLine”,”width”:”100%”,”height”:”350px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:13,”color”:”#383838″,”primaryLineColor”:”#000″,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#000″,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#ba0000″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#fff”,”scrollbarSelectedBackgroundColor”:”#000″,”scrollbarGraphFillColor”:”#000″,”scrollbarSelectedGraphFillColor”:”#000″,”primaryLineThickness”:0,”secondaryLineThickness”:0,”gridThickness”:0,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”mouseWheelZoomEnabled”:false,”cursorEnabled”:false,”exportEnabled”:false,”scrollbarEnabled”:false,”legendEnabled”:false,”periods”:”1W,1M,6M,YTD,1Y,ALL”,”defaultPeriod”:”1y”}’]
Key Share Information:
Current Share Price #N/A
Market Capitalization (in Millions) #N/A
Last Quarter (Share Data) 3/31/2019
Shares Outstanding (in Millions) 416.66
Options (in Millions) 56.19
Warrants (in Millions) 59.62
Fully Diluted (in Millions) 532.48
Enterprise Value (in MIllions) #N/A
TTM Revenue $0.84
TTM Growth Margin % 0.00%
TTM Operating Expenses $22.50
TTM OCF -$0.80
P/S TTM #N/A
P/S (Last Quarter Run Rate) #N/A
Key Balance Sheet Information (in Millions $CAD):
CYQ3'16 CYQ4'16 CYQ1'17 CYQ2'17 CYQ3'17 CYQ4'17 CYQ1'18 CYQ2'18 CYQ3'18 CYQ4'18 CYQ1'19
Cash $0.49 $0.21 $0.19 $0.08 $2.02 $3.47 $16.21 $11.10 $6.57 $2.92 $1.25
Biological Assets
Inventory $0.00
Total Assets $8.05 $5.69 $6.46 $5.42 $2.75 $6.41 $22.99 $21.51 $20.74 $23.53 $24.60
Net Tangible Assets $8.05 $5.69 $6.46 $5.42 $2.75 $6.41 $22.99 $21.51 $20.74 $23.53 $24.60
Intangibles/Goodwill
Total Liabilities $0.50 $0.74 $1.06 $1.42 $1.17 $0.65 $3.31 $3.13 $3.06 $3.59 $7.20
Key Operating Items (Quarterly in Millions $CAD):
CYQ3'16 CYQ4'16 CYQ1'17 CYQ2'17 CYQ3'17 CYQ4'17 CYQ1'18 CYQ2'18 CYQ3'18 CYQ4'18 CYQ1'19
Revenue $0.26 $0.02 $0.34 $0.25 $0.23
Change in Fair Value of Biologial Assets
Gross Margin
Marketing and Sales
Investor Relations $0.07 $0.01 $0.02 $0.02 $0.14 $0.04 $0.05 0.08 0.22 $0.06 $0.03
Total Operating Expenses $7.81 $0.50 $0.57 $0.40 $4.86 $4.45 $1.36 0.31 16.87 $2.16 $3.16
Operating Cash Flow (Quarterly) -$4.44 -$0.06 $0.31 -$2.42 -$0.02 -0.48 -3.16 $3.05 -$0.21
Investing Cash Flow (Quarterly) -$1.46 -$0.01 -$0.13 $0.94 $0.26 -2.97 -5.56 $6.90 $0.38
Financing Cash Flow (Quarterly) $0.38 $0.33 -$0.28 $3.13 $11.00 -14.31 18.35 -$18.15 $1.81
Listing Statement
